Angiotensin converting enzyme inhibitors/angiotensin receptor blockers (ACEIs/ARBs), unless otherwise contraindicated, are drugs of first choice in patients with essential hypertension with LVH12-16. This evidence concerns the gene ACE and hypertensive disorder.